As powerful mediators of inflammation, complement proteins have been implicated for a role in tumorigenesis [5], with elevated complement regulatory proteins and activation fragments identified as biomarkers and prognostic indicators for many cancers, including breast cancer [6,7,8]. The gene discussed is VTN; the disease is breast cancer.